in June we had a little workshop on the festival Pixelache in Helsinki on the topic of the Commons (e.g. creative commons).
There, a number of biohackers and citizens from Europe and Asia discussed ways to make the concept of the commons (e.g. creative commons) fruitful for the life science.
Citizens proposed a ‘Bio-Commons’ license model to put biological innovation into service to society and at the same time limit the potential misuse of knowledge and material.
Taking the antibiotic resistance problem as an example, this whitepaper aims to demonstrate the necessity and feasibility of a Bio-Commons approach.
In a citizen science project dubbed ‘Biostrike’, people around the globe could contribute to the solution to the antibiotics problem by raising awareness on the issue.
Citizens and Scientists could participate in a global community around Biostrike, collaborating to find new antibiotics. Specialists from all fields of expertise could put together their knowledge to build the tool sets – that is wetware, hardware and software - to enable decentralized research on antibiotics. The Bio-Commons license could make licensing of innovation and discovery easier for researchers and thereby stabilize global collaborations that will help overcome market failure situations as they exist in antibiotics research.
A widely accepted regulatory framework would be required to provide legal security and reliability as well as equal, transparent, and fair terms for all participants.
Opening up the Bio-Commons discussion and introducing democratic decision making will make everybody a stakeholder.
It was thought that the blockchain technology could in future comprise the technical infrastructure for the Bio-Commons.
Please read the whitepaper and contribute to the development of the idea on github!